Novel DNA microarray chip predicts functional impairment and remission in rheumatoid arthritis
Paris, France, Friday 13 June 2008: A new DNA microarray chip can predict severe disability and remission in patients with rheumatoid arthritis (RA), as presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France. The chip (called the 'ARTchip') has yielded two clinical-genetic models of RA outcomes, to assist physicians in anticipating likely disease progression and prognosis and thereby guide decisions on the best course of treatment for individual patients. The DNA microarray chip was developed as a tool to study 71 gene polymorphisms (tiny variations in the DNA that can cause or have a role in RA disease activity) in 45 genes chosen specifically for their presumed role in RA.
Dr Alejandro Balsa, of University Hospital La Paz, Madrid, Spain, who led the study, said: "Prognostic markers, identified through our microarray chip, can be used to predict disease outcomes in RA patients which may help healthcare professionals to choose the best treatment for each patient depending on their level of disease activity."
Predicting Severe Disability
6% and 8% of patients in the study and validation populations had a Health Assessment Questionnaire (HAQ) score of 2 or more indicating severe disability due to RA. The results from the DNA array significantly improved the ability of clinical scores to predict functional impairment.
Results of the study showed that clinical scores in combination with the DNA array had a high level of accuracy when compared in the two independent populations (sensitivity (S): 41%, specificity (Sp): 95% and likelihood ratio (LR): 7.6 in the study group, and S: 21%, Sp: 95% and LR: 4.4 in the validation population).
Overall, 6% and 7% of patients in the study and validation groups, respectively fell into the disease remission category. The results from the clinical scores in combination with the DNA array also accurately predicted remission in patients with RA, with S: 76%, Sp: 86%, LR: 5.4 compared withand S: 76%, Sp: 75%, LR: 3.1 respectively.
A total of 632 patients fulfilling the American College of Rheumatology (ACR) criteria for RA, with disease onset after 1990 and at least five-year disease duration, were analysed. Baseline variables were recorded including age, gender, smoking, joint counts, acute phase reactants and the presence of anti-CCP antibodies and rheumatoid factor. Remission was defined as absence of joint symptoms without disease-modifying anti-rheumatic drug (DMARD) therapy. Severe disability was defined as an HAQ score of 2 or more. Genetic association analyses were performed with HelixTree. Multivariate logistic regression models and ROC curves, to determine sensitivity, specificity and likelihood ratio, were developed with SPSS software.
Predictive models were initially developed for 375 patients and further validated on 257 RA patients. More than three quarters of the studied cases (77%) were females, and had with 10.9±3.6 years' disease duration.
A DNA array (or DNA chip) is a technique commonly used in molecular biology where tiny spots of specific DNA are arranged on a solid substance (normally glass). This technique can be used to screen thousands of genes in a single test, for their association with a particular disease or a specific clinical phenotype. In this study, a DNA array was developed and used to identify SNPs that can help to predict the course of RA. Moreover, the study provides rheumatologists with a tool to predict RA aggressiveness, based on a weighted combination of clinical and genetic parameters.
- Hand bone mineral density is an effective predictor of mortality in rheumatoid arthritisThu, 12 Jun 2008, 10:36:22 EDT
- Sex lives of patients are negatively affected by rheumatoid arthritis and SLEFri, 18 Jun 2010, 8:02:56 EDT
- Targeting disease remission has socio-economic benefits over low disease activitySat, 19 Jun 2010, 3:32:14 EDT
- Tracking levels of key biomarkers reflects disease activity and progression of rheumatoid arthritisMon, 15 Jun 2009, 9:37:32 EDT
- Increased levels of certain cytokines and chemokines predict onset of rheumatoid arthritisMon, 15 Jun 2009, 9:37:33 EDT
Articles on the same topic
- CV risk management should be mandatory in RA and other types of inflammatory rheumatic diseaseFri, 13 Jun 2008, 14:23:25 EDT
- New insight into RA patient priorities and motivators for clinical trial involvementFri, 13 Jun 2008, 11:43:37 EDT
- Rheumatoid arthritis is a risk factor for cardiovascular diseaseFri, 13 Jun 2008, 11:43:23 EDT
- Rheumatoid arthritis factors equal to cardiovascular factors in risk of severe cardiovascular eventsFri, 13 Jun 2008, 11:43:18 EDT
- Abatacept and infliximab improve clinical response over time in methotrexate-refractory RA patientsFri, 13 Jun 2008, 11:43:16 EDT
- Lupus more severe in patients with southern European ancestryFri, 13 Jun 2008, 11:43:06 EDT
- 50 percent of recent onset RA patients become free of signs and symptoms within 36 weeksFri, 13 Jun 2008, 11:43:03 EDT
- Phase 3 studies show golimumab significantly improved signs and symptoms of rheumatoid arthritisFri, 13 Jun 2008, 11:42:59 EDT
- Phase 3 data show efficacy of golimumab in RA patients previously treated with anti-TNF agentsFri, 13 Jun 2008, 11:42:55 EDT
- New Treatment For Rheumatoid Arthritis Leaves 50 Percent Of Recent Onset Patients Symptom-free Within 36 Weeksfrom Science DailyMon, 16 Jun 2008, 12:28:27 EDT
- Rheumatoid arthritis is a risk factor for cardiovascular diseasefrom PhysorgFri, 13 Jun 2008, 11:42:16 EDT
Latest Science NewsletterGet the latest and most popular science news articles of the week in your Inbox! It's free!
Learn more about
Check out our next project, Biology.Net
From other science news sites
Popular science news articles
- Mars had oxygen-rich atmosphere 4,000 million years ago
- Outlook is grim for mammals and birds as human population grows
- The contribution of particulate matter to forest decline
- Scientists find new source of versatility so 'floppy' proteins can get things done
- An environmentally friendly battery made from wood
- Even with defects, graphene is strongest material in the world
- Detection of the cosmic gamma ray horizon: Measures all the light in the universe since the Big Bang
- Genetic engineering alters mosquitoes' sense of smell
- Allosaurus fed more like a falcon than a crocodile, new study finds
- 'Popcorn' particle pathways promise better lithium-ion batteries